Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
18,643,979
-
Shares change
-
+881,898
-
Total reported value, excl. options
-
$135,914,431
-
Value change
-
+$6,591,352
-
Put/Call ratio
-
103%
-
Number of buys
-
36
-
Number of sells
-
-25
-
Price
-
$7.29
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2024
85 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q2 2024.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,643,979 shares
of 92,448,158 outstanding shares and own 20% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (7,099,182 shares), Avoro Capital Advisors LLC (3,999,999 shares), VANGUARD GROUP INC (1,269,466 shares), BlackRock Inc. (1,129,143 shares), FMR LLC (1,108,747 shares), GEODE CAPITAL MANAGEMENT, LLC (463,362 shares), STATE STREET CORP (451,780 shares), Propel Bio Management, LLC (424,937 shares), Invesco Ltd. (423,520 shares), and Simplify Asset Management Inc. (280,000 shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.